Valentina Zuco - Wissenschaftliche Veröffentlichungen

(1 - 4 von 5

)

Targeting the Akt Kinase to Modulate Ingenta Connect

www.ingentaconnect.com

von G Cassinelli · · Zitiert von: 100 — Targeting the Akt Kinase to Modulate Survival, Invasiveness and Drug. Resistance of Cancer Cells. Giuliana Cassinelli. 1. , Valentina Zuco. 1. , Laura Gatti. › ben › cmc › art00001

Selinexor versus doxorubicin in dedifferentiated liposarcoma ...

jeccr.biomedcentral.com

von V Zuco · · Zitiert von: 9 — Valentina Zuco and Sandro Pasquali contributed equally to this work. 1Molecular Pharmacology Unit, Department of Applied Research and. › track › pdf

Cyclic Pifithrin-α Sensitizes Wild Type p53 Tumor Cells to...

www.sciencedirect.com

Cyclic Pifithrin-α Sensitizes Wild Type p53 Tumor Cells to Antimicrotubule Agent–Induced Apoptosis1. Valentina Zuco. x. Valentina Zuco. Search for articles by ...

Drug Combinations with Proteasome Inhibitors in Antitumor Therapy:...

www.ingentaconnect.com

Laura Gatti*, Valentina Zuco, Nadia Zaffaroni and Paola Perego. Molecular Pharmacology Unit, Department of Experimental Oncology and Molecular Medicine, ...

Verwandte Suchanfragen zu Valentina Zuco

Franco Zunino
Laura Gatti
Silvia Martini

Personen
Vorname "Valentina" (6204)
Name "Zuco" (7)

sortiert nach Relevanz / Datum

Erweiterte Suche

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Wissenschaftliche Veröffentlichungen Valentina Zuco

Targeting the Akt Kinase to Modulate Ingenta Connect

Selinexor versus doxorubicin in dedifferentiated liposarcoma ...

Cyclic Pifithrin-α Sensitizes Wild Type p53 Tumor Cells to...

Drug Combinations with Proteasome Inhibitors in Antitumor Therapy:...